Blood Journal
Leading the way in experimental and clinical research in hematology

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma

  1. Joshua Richter1,
  2. Natalia Neparidze1,
  3. Lin Zhang1,
  4. Shiny Nair1,
  5. Tamara Monesmith2,
  6. Ranjini Sundaram1,
  7. Fred Miesowicz2,
  8. Kavita M. Dhodapkar3, and
  9. Madhav V. Dhodapkar1,*
  1. 1 Department of Medicine, Yale University School of Medicine, New Haven, CT, United States;
  2. 2 Argos Therapeutics, Durham, NC, United States;
  3. 3 Department of Pediatrics, Yale University School of Medicine, New Haven, CT, United States
  1. * Corresponding author; email: madhav.dhodapkar{at}yale.edu
PDF Container